[Federal Register Volume 74, Number 118 (Monday, June 22, 2009)]
[Notices]
[Page 29503]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14498]



[[Page 29503]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse, Special 
Emphasis Panel NIDA Statistical and Computational Genetics R25.
    Date: June 29, 2009.
    Time: 10 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Executive Blvd, Rockville, 
MD 20852 (Telephone Conference Call).
    Contact Person: Mark Swieter, PhD. Chief, Training and Special 
Projects Review Branch, Office of Extramural Affairs, National 
Institute on Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Suite 
220, Bethesda, MD 20892-8401. (301) 435-1389. <a href="/cdn-cgi/l/email-protection#93fee0aba3ebd3fdfafbbdf4fce5"><span class="__cf_email__" data-cfemail="09647a31397149676061276e667f">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse, Special 
Emphasis Panel Program Project (P01) Applications.
    Date: July 1, 2009.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Jose F Ruiz, PhD., Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, 6101 Executive Blvd., Rm. 213, MSC 8401, Bethesda, 
MD 20892. 301-451-3086. <a href="/cdn-cgi/l/email-protection#f280879b889894b29c9b9693dc9c9b9adc959d84"><span class="__cf_email__" data-cfemail="1b696e7261717d5b75727f7a35757273357c746d">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse, Special 
Emphasis Panel I/START Review Panel.
    Date: July 2, 2009.
    Time: 8:30 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Gerald L. McLaughlin, PhD., Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., 
Bethesda, MD 20892-8401. 301-402-6626. <a href="/cdn-cgi/l/email-protection#bbdcd68a8f8edafbd5d2d395dcd4cd"><span class="__cf_email__" data-cfemail="aec9c39f9a9bcfeec0c7c680c9c1d8">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse, Special 
Emphasis Panel NIDA Avant-Garde Award.
    Date: July 14-15, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Westin Grand, 2350 M Street, NW., Washington, DC 20037.
    Contact Person: Nadine Rogers, PhD., Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401. 301-402-2105. <a href="/cdn-cgi/l/email-protection#5e2c31393b2c2d306c1e30373a3f7030373670393128"><span class="__cf_email__" data-cfemail="eb99848c8e999885d9ab85828f8ac5858283c58c849d">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: June 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-14498 Filed 6-19-09; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>